Two Years of SARS-CoV-2 Infection (2019–2021): Structural Biology, Vaccination, and Current Global Situation January 2022 in “ The Egyptian Journal of Internal Medicine ” Waqar Ahmad, Khadija Shabbiri We don't know much about this study yet. We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study. View this study on ejim.springeropen.com →
research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19 70 citations , July 2020 in “Pharmacological Reports” Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.